-
Fighting South Africa lose Rickelton after India 189 all out
-
Harmer leads South Africa fightback as India 189 all out
-
Prison looms for Brazil's Bolsonaro after court rejects his appeal
-
EU bows to pressure on loosening AI, privacy rules
-
India close in on lead despite South African strikes
-
Curry's 49 points propel Warriors in 109-108 win over Spurs
-
NZ boxer Parker denies taking banned substance after failed test
-
Australia setback as Hazlewood ruled out of 1st Ashes Test
-
Australia pace spearhead Josh Hazlewood ruled out of 1st Ashes Test
-
UN Security Council to vote Monday on Trump Gaza plan
-
Japan's Tomono leads after men's short program at Skate America
-
China tells citizens to avoid Japan travel as Taiwan row grows
-
Purdue Pharma to be dissolved as US judge says to approve bankruptcy
-
Iran's first woman orchestra conductor inspires
-
Wood gets all-clear in boost for England
-
Golf's world No. 8 Thomas has back surgery
-
Rebooted Harlem museum celebrates rise of Black art
-
'Desperation in the air': immigrant comics skewer Trump crackdown
-
UN regulator says shipping still wants to decarbonize -- despite US threats
-
Grant, Kim share halfway lead in LPGA Annika tournament
-
Musk's Grokipedia leans on 'questionable' sources, study says
-
Trump signs order to lower tariffs on beef, coffee, other goods
-
Croatia qualify for 2026 World Cup, Netherlands close, Germany in limbo
-
'Last Chance U' coach dies after shooting: US police
-
Sinner completes perfect ATP Finals group stage, Auger-Aliassime reaches last four
-
Woltemade sends Germany past Luxembourg in World Cup qualifier
-
Croatia qualify for 2026 World Cup with 3-1 win over Faroes
-
Kai Trump makes strides but still misses cut in LPGA debut
-
Return to bad days of hyperinflation looms in Venezuela
-
US airspace recovers as budget shutdown ends
-
Russia strike on Kyiv apartment block kills six, Ukraine says
-
Arrest made in shooting of 'Last Chance U' coach: US police
-
At COP30, senator warns US 'deliberately losing' clean tech race with China
-
US, Switzerland say deal reached on trade and tariffs
-
Fossil fuel lobbyists out in force at Amazon climate talks: NGOs
-
Returning Alldritt blames himself for France axing
-
Stocks struggle on US rates, tech rally fears
-
A rare oil CEO shows up at COP30, spars with activists
-
Trump demands probe into Epstein links to Bill Clinton
-
England great Anderson says 'weak' Australia still Ashes favourites
-
Indigenous protesters disrupt UN climate summit again
-
Gun salutes for King Charles III as he marks 77th birthday
-
Ford urges England to make their own New Zealand history
-
Acosta top in Valencia MotoGP practice as Martin returns
-
Michelle Yeoh to get honorary award at Berlin film fest
-
Bulgaria names manager to take over Russia's Lukoil refinery after US sanctions
-
Spain players on their way to becoming 'legendary': coach De la Fuente
-
US, Switzerland say reached deal on trade and tariffs
-
Saudi prince, eyeing defence pledge, to meet Trump after long US absence
-
Water shortage pushes Kyrgyzstan, Tajikistan into energy crisis
Dalrada Financial Corporation's Deposition Technology Makes Spectroptix(R) Available for Advance Ordering
Deptec's plasma spectrometer is primed to play an integral role in the booming semiconductor manufacturing and thin-film sectors.
Dalrada Financial Corporation(OTC PINK:DFCO), "Dalrada," "the Company"), announced today that Spectroptix®, a proprietary advanced plasma spectrometer developed by its subsidiary, Deposition Technology ("Deptec,"), is now available for advance ordering.
The one-of-a-kind spectrometer is designed for precise element detection in vacuum chambers during deposition or semiconductor manufacturing processes, allowing for the integration of advanced plasma spectroscopy. This specialized tool also offers a host of other key features and benefits, according to Brian Bonar, Dalrada's Chairman and CEO.
"Spectroptix® is the ideal machine for the semiconductor industry," said Bonar. "For starters, it can be integrated into various vacuum-based processes, from thin film coatings to plasma-enhanced CVD and PVD systems. It's also quite easy to operate. Spectroptix® will be a real game-changer in the microchip and semiconductor world and we're quite thrilled to offer pre-ordering for our clients."
Deptec's Spectroptix® delivers real-time actionable data on materials within each vacuum chamber during the deposition process, ensuring higher accuracy, efficiency, and process control. Other benefits of the advanced spectrometer include:
Plasma creation: a background plasma independent of the deposition process, ensuring that no process contamination or interference occurs during analysis.
Enhanced Process Control: using real-time data, Spectroptix® enables precise control over deposition environments, allowing for on-the-fly adjustments to gas flow or composition.
User-Friendly Interface: intuitive software control that allows remote operation for operators to visualize and analyze light spectrum data for efficient optimization.
Preferred over Residual Gas Analyzers (RGAs): more cost-effective solution than RGAs, plus RGAs do not come standard with vacuum technology.
Deptec's Spectroptix® is particularly well-suited for applications requiring ultra-thin films and sensitive optical coatings, like semiconductor manufacturing, microelectronics, optoelectronics, advanced material processing, and more. Future target markets include pharmaceuticals, aerospace/defense, materials science, nuclear industries, and food and beverage.
With a mature product line firmly in place within the deposition technology marketplace, Deptec has its sights on further expanding its unique portfolio, adding robust solutions to include a new chemical vapor deposition (CVD) platform-the EVOS CVD system-which would join the company's popular Novellus C1 upgrade kit for legacy CVD machines.
"With our increased production and installation capabilities plus the rollout of new products providing even greater opportunities, making Spectroptix® available for pre-ordering is just the beginning," added Bonar.
About Dalrada Financial Corporation
Dalrada Financial Corporation(OTC PINK:DFCO) is a multi-national holding company that develops, manufactures, and sells a robust suite of products and services in the Clean Energy, Physical and Chemical Vapor Deposition for Semiconductors, and Health Care sectors. Dalrada's core segments include Dalrada Climate Technology, which offers cutting-edge heat pump and energy sustainability technology for industrial and residential applications; Deptec, an international leader in deposition technology and manufacturing that repurposes and sells proprietary semiconductor technology for clean energy applications; and Genefic Specialty Pharmacy, which provides end-to-end prescription and specialty pharmacy services as well as patient advocacy and support.
Dalrada consistently drives innovation that delivers maximum impact, bringing increased value to its shareholders.
For more information, please visit www.dalrada.com, and follow us on LinkedIn, Facebook, Twitter, and YouTube.
About Deposition Technology
Deposition Technology (Deptec) is a wholly-owned subsidiary of Dalrada Financial Corporation(OTC PINK:DFCO), and an international leader in precision manufacturing, specializing in thin-film deposition including PVD (Physical Vapor Deposition) and CVD (Chemical Vapor Deposition) processing and equipment.
Founded in 2004, Deptec has expanded to specialize in upgrading legacy tools, including Novellus Concept One, and delivering innovative solutions like Spectroptix for advanced material detection. The company's products and services are designed to enhance the performance, reliability, and cost-efficiency of manufacturing processes in the semiconductor, MEMS, and optoelectronics industries.
Forward-Looking Statements
Statements contained in this press release, other than statements of historical fact, particularly statements relating to cost reductions and the anticipated pre-tax savings from the cost reduction program, restructuring costs, footprint rationalization, simplifying and streamlining our operations, reducing complexity, enhancing the speed of decision-making, leveraging our sourcing capabilities and the timing of implementation and completion of the cost reduction program, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management based on information available to us at the time such statements are made. These statements, which are generally identifiable by the use of the words "will," "believe," "expect," "intend," "anticipate," "estimate," "forecast," "project," "plan," and similar expressions, are subject to certain risks and uncertainties, are made as of the date hereof, and we undertake no duty or obligation to update them. Forward-looking statements are subject to the occurrence of many events outside the Company's control and actual results and the timing of events may differ materially from those suggested or implied by such forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the US Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.
Media contact: Michael Eslinger ([email protected])
# # #
SOURCE: Dalrada Financial Corporation
D.Moore--AMWN